Trial intelligence / Profile preview

Sevoflurane vs Desflurane on Microcirculation in OPCAB

NCT03209193Phase 4Completed

Sponsor
Seoul National University Hospital
Start
Jul 2017
Primary completion
Nov 2019
Modality
Allosteric Modulators
Countries
1
01

Overview

A Phase 4 trial of sevoflurane, desflurane in coronary artery disease (CAD), sponsored by Seoul National University Hospital. Started Jul 2017; status: completed.

02

Drugs

sevofluranedesflurane
03

Conditions

coronary artery disease (CAD)

Beyond the preview

Go deeper on NCT03209193.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03209193.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call